Methods and compositions for prevention or treatment of RSV infection

摘要

The instant specification relates to the use of siRNA for the treatment of Respiratory Syncytial Virus (RSV) infection in patients and animals. The subject of the treatment includes immunocompromised individuals such as patients undergoing transplantation procedures. The delivery method of the siRNA includes intranasal and intrapulmonary delivery for neutralising RSV infection. WO 2009/076679 PCT/US2008/086889 In vitro silencing of RSV by siRNAs 40 - - - il siRNAs (5nM)